Through R&D innovations and collaborative partnerships, we're investing in cutting-edge research to open the door for new assay development.
Join us at CTAD2026 and speak to our experts about blood-based biomarkers for neurodegenerative diseases.
Improving Access to blood-based biomarkers
We are partnering with leading clinical researchers to create a discovery ecosystem, unlocking the full potential of the latest scientific advances and developing a robust portfolio of highly sensitive RUO assays, including our new BD-pTau217 assay, that can ultimately be used to advance neurodegenerative disease diagnostics to enable earlier disease detection.
Together, we are changing the paradigm of patient care with less invasive assays that deliver more insights into neurodegenerative disease.
| Assays for Research Use Only | IFU | Information Bulletin |
| BD-pTau 217 | Link | Link |
| p-Tau217 | Link | Link |
| GFAP | Link | Link |
| NfL | Link | Link |
| APOE ε4 | Link | Link |
| ß-AmyIoid 1-42 | Link | Link |
| BD-Tau | Link | Link |
| Research Use Only Assays in Development | ||
| p‑Tau205 | ||
For Research Use Only. Not for use in diagnostic procedures.
Wednesday, November 18, 2026
Oral Communication | 4:45 PM
OC39 Combining Plasma p-Tau217 with Proteomic Signatures Enables Graded Risk Stratification for Alzheimer’s Disease Progression
Presenter: Menghan Liu
Posters | 7:15 AM – 5:30 PM
P244 Ratio-Based Plasma p-Tau217 Biomarkers Outperform Single Measures for Detecting Early Amyloid Pathology in Preclinical AD
Presenter: James D. Doecke
P250 Plasma and Tau-PET Reflect Distinct Biological Processes Underlying Cognitive Decline in Alzheimer’s Disease
Presenter: James D. Doecke
P267 From Stackers to Streamliners: Alzheimer’s Disease Work-up Archetypes and the Impact of AD BBM Ratio Test Results on Diagnostic Escalation
Presenter: Trever Burgon
P293 Novel High-Throughput, Fully Automated Immunoassay for Cerebrospinal Fluid Phosphorylated Tau205
Presenter: Ben Schlichtmann
Tuesday, Nov. 17: Morning Panel Discussion
7:15 – 8:30 AM
Salons K & J, Fourth Floor, Marriott Copley Place
The Real-World Alzheimer’s Disease Patient Journey: Current Challenges and Future Opportunities
Sponsored by Danaher and GE Healthcare
Wednesday, Nov. 18: Morning Panel Discussion
7:15 – 8:30 AM
Salons K & J, Fourth Floor, Marriott Copley Place
Implementation of Blood-Based Biomarker Testing in Neurodegenerative Disease
Sponsored by Danaher and Beckman Coulter
Evening Reception: Wednesday, Nov. 18
6:15 – 7:15 PM
Salon B, Fourth Floor, Marriott Copley Place
Expert Roundtables on the Future of Blood-based Biomarkers
Sponsored by Beckman Coulter and Danaher
Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow.
What differentiates Danaher is not only what we do, but how we do it—accelerating the journey from idea to impact through a connected ecosystem of companies, deep scientific expertise, and a culture of continuous improvement powered by the Danaher Business System.
Working as one Danaher, our businesses bring the right combination of technologies, scale and partnership to solve the hardest problems—and help customers move from discovery to delivery faster.
Genedata transforms biopharma data into intelligence. Our innovative software solutions combine deep science, technology, and AI domain knowledge. Leading biopharma organizations and cutting-edge biotechs partner with Genedata to digitalize and automate complex data workflows.
Our advanced analytics and embedded AI enable data-driven decisions. From early discovery through development to the clinic, Genedata solutions drive innovation and maximize ROI being trusted by customers worldwide for more than 25 years.
Tell us you’re coming, and we’ll connect you with a member of the Beckman Coulter team
Complete the form below and someone will reach out to you soon.
Thank you for your request.
A Beckman Coulter representative will contact you shortly.
English
